Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C

H. Tanaka, M. Miyano, H. Ueda, Koji Fukui, M. Ichinose

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

One of the side effects by interferon ribavirin (I/R) treatment is haemolytic anemia, causing some patients to discontinue I/R treatment. The exact mechanism of I/R-induced anemia is unknown. The aim of this study is to evaluate the effects of I/R treatment on the serum lipid and red blood cell (RBC) membrane lipid profiles of patients with chronic hepatitis C (CHC) and the association between changes of RBC membrane lipids and haemolytic anemia by I/R treatment. Fourteen patients with CHC were treated with I/R and their serum lipid profiles were studied. In addition, in seven of the 14 patients, the RBC membrane lipid profiles were analysed. In the RBC membrane lipid composition, the total cholesterol, total phospholipids and cholesterol/phospholipids (C/PL) ratio were significantly increased. Phosphatidylcholine (PC) and the phosphatidylcholine/sphingomyelin (PC/SM) ratio were significantly decreased and other phospholipid fractions were significantly increased. Changes in the serum lipids and RBC membrane lipid profiles of patients with CHC treated with I/R were shown. Especially, a decrease in the RBC deformability and membrane fluidity by changes in these RBC membrane lipids was supposed and it is suggested that those changes may result in haemolytic anemia by I/R treatment.

Original languageEnglish
Pages (from-to)190-195
Number of pages6
JournalClinical and Experimental Medicine
Volume5
Issue number4
DOIs
Publication statusPublished - 2005 Dec
Externally publishedYes

Fingerprint

Ribavirin
Membrane Lipids
Interferons
Blood
Phospholipids
Phosphatidylcholines
Lipids
Cholesterol
Sphingomyelins
Fluidity
Formability
Association reactions
Membranes
Chemical analysis

Keywords

  • Chronic hepatitis C
  • Interferon ribavirin treatment
  • Red blood cell membrane lipids
  • Serum lipids

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Clinical Biochemistry

Cite this

Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C. / Tanaka, H.; Miyano, M.; Ueda, H.; Fukui, Koji; Ichinose, M.

In: Clinical and Experimental Medicine, Vol. 5, No. 4, 12.2005, p. 190-195.

Research output: Contribution to journalArticle

@article{95ca078cb0524690a3aa11e77dc18dab,
title = "Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C",
abstract = "One of the side effects by interferon ribavirin (I/R) treatment is haemolytic anemia, causing some patients to discontinue I/R treatment. The exact mechanism of I/R-induced anemia is unknown. The aim of this study is to evaluate the effects of I/R treatment on the serum lipid and red blood cell (RBC) membrane lipid profiles of patients with chronic hepatitis C (CHC) and the association between changes of RBC membrane lipids and haemolytic anemia by I/R treatment. Fourteen patients with CHC were treated with I/R and their serum lipid profiles were studied. In addition, in seven of the 14 patients, the RBC membrane lipid profiles were analysed. In the RBC membrane lipid composition, the total cholesterol, total phospholipids and cholesterol/phospholipids (C/PL) ratio were significantly increased. Phosphatidylcholine (PC) and the phosphatidylcholine/sphingomyelin (PC/SM) ratio were significantly decreased and other phospholipid fractions were significantly increased. Changes in the serum lipids and RBC membrane lipid profiles of patients with CHC treated with I/R were shown. Especially, a decrease in the RBC deformability and membrane fluidity by changes in these RBC membrane lipids was supposed and it is suggested that those changes may result in haemolytic anemia by I/R treatment.",
keywords = "Chronic hepatitis C, Interferon ribavirin treatment, Red blood cell membrane lipids, Serum lipids",
author = "H. Tanaka and M. Miyano and H. Ueda and Koji Fukui and M. Ichinose",
year = "2005",
month = "12",
doi = "10.1007/s10238-005-0085-0",
language = "English",
volume = "5",
pages = "190--195",
journal = "Zeitschrift fü Die Gesamte Experimentelle Medizin",
issn = "1591-8890",
publisher = "Springer-Verlag Italia",
number = "4",

}

TY - JOUR

T1 - Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C

AU - Tanaka, H.

AU - Miyano, M.

AU - Ueda, H.

AU - Fukui, Koji

AU - Ichinose, M.

PY - 2005/12

Y1 - 2005/12

N2 - One of the side effects by interferon ribavirin (I/R) treatment is haemolytic anemia, causing some patients to discontinue I/R treatment. The exact mechanism of I/R-induced anemia is unknown. The aim of this study is to evaluate the effects of I/R treatment on the serum lipid and red blood cell (RBC) membrane lipid profiles of patients with chronic hepatitis C (CHC) and the association between changes of RBC membrane lipids and haemolytic anemia by I/R treatment. Fourteen patients with CHC were treated with I/R and their serum lipid profiles were studied. In addition, in seven of the 14 patients, the RBC membrane lipid profiles were analysed. In the RBC membrane lipid composition, the total cholesterol, total phospholipids and cholesterol/phospholipids (C/PL) ratio were significantly increased. Phosphatidylcholine (PC) and the phosphatidylcholine/sphingomyelin (PC/SM) ratio were significantly decreased and other phospholipid fractions were significantly increased. Changes in the serum lipids and RBC membrane lipid profiles of patients with CHC treated with I/R were shown. Especially, a decrease in the RBC deformability and membrane fluidity by changes in these RBC membrane lipids was supposed and it is suggested that those changes may result in haemolytic anemia by I/R treatment.

AB - One of the side effects by interferon ribavirin (I/R) treatment is haemolytic anemia, causing some patients to discontinue I/R treatment. The exact mechanism of I/R-induced anemia is unknown. The aim of this study is to evaluate the effects of I/R treatment on the serum lipid and red blood cell (RBC) membrane lipid profiles of patients with chronic hepatitis C (CHC) and the association between changes of RBC membrane lipids and haemolytic anemia by I/R treatment. Fourteen patients with CHC were treated with I/R and their serum lipid profiles were studied. In addition, in seven of the 14 patients, the RBC membrane lipid profiles were analysed. In the RBC membrane lipid composition, the total cholesterol, total phospholipids and cholesterol/phospholipids (C/PL) ratio were significantly increased. Phosphatidylcholine (PC) and the phosphatidylcholine/sphingomyelin (PC/SM) ratio were significantly decreased and other phospholipid fractions were significantly increased. Changes in the serum lipids and RBC membrane lipid profiles of patients with CHC treated with I/R were shown. Especially, a decrease in the RBC deformability and membrane fluidity by changes in these RBC membrane lipids was supposed and it is suggested that those changes may result in haemolytic anemia by I/R treatment.

KW - Chronic hepatitis C

KW - Interferon ribavirin treatment

KW - Red blood cell membrane lipids

KW - Serum lipids

UR - http://www.scopus.com/inward/record.url?scp=29144469243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144469243&partnerID=8YFLogxK

U2 - 10.1007/s10238-005-0085-0

DO - 10.1007/s10238-005-0085-0

M3 - Article

C2 - 16362799

AN - SCOPUS:29144469243

VL - 5

SP - 190

EP - 195

JO - Zeitschrift fü Die Gesamte Experimentelle Medizin

JF - Zeitschrift fü Die Gesamte Experimentelle Medizin

SN - 1591-8890

IS - 4

ER -